Results: Nine patients were enrolled and prospectively followed up. Mean baseline values of BCVA, CPT, TMV, and CST were 0.8±0.1 (logMAR±SD), 340±49µm, 7.14±0.05mm 3 , and 366±37μm, respectively. At the 4-month examination following STLT, mean BCVA improved to 0.6±0.2, whereas mean CPT, TMV, and CST decreased to 274±29µm, 6.87±0.11mm 3 , and 296±33μm. At the 12-month examination, mean BCVA was 0.36±0.2, mean CPT was 195±11µm, mean TMV was 6.55±0.19mm 3 , and mean CST was 239±14μm, respectively. No side-effects were noted. In particular, no sign of retinal thinning and underlying backscattering typical of conventional laser treatment could be detected at the site of the laser application on OCT.Conclusion: The current pilot investigation of STLT for the treatment of symptomatic RAM shows encouraging data. A randomized clinical trial is required to ascertain the real efficacy this technique and the most appropriate settings to be employed.